Parvo Shield L5EThis page contains information on Parvo Shield L5E for veterinary use.
The information provided typically includes the following:
- Parvo Shield L5E Indications
- Warnings and cautions for Parvo Shield L5E
- Direction and dosage information for Parvo Shield L5E
Parvo Shield L5EThis treatment applies to the following species:
Erysipelothrix Rhusiopathiae-Leptospira Canicola-Grippotyphosa-Hardjo-Icterohaemorrhagiae-Pomona Bacterin
For Use In Animals Only
Parvo Shield L5E Indications
For use in healthy swine as an aid in the prevention of disease caused by porcine parvovirus, Erysipelothrix rhusiopathiae, Leptospira canicola, grippotyphosa, hardjo, icterohaemorrhagiae, and pomona.
Adjuvant: Aluminum hydroxide.
Directions For Use
Shake well before using. Inject 5 mL intramuscularly to gilts and sows 4-6 weeks prior to breeding. Repeat in 3-4 weeks. Revaccinate with a single dose 4-6 weeks prior to each subsequent breeding. Vaccinate boars semiannually.
PrecautionsStore out of direct sunlight at 2°-7° C (35°-45° F). Do not freeze. Use entire contents when first opened. Do not vaccinate within 21 days prior to slaughter. Anaphylactic reactions may occur. Symptomatic treatment: Epinephrine. Contains amphotericin B, gentamicin, and thimerosal as preservatives.
U.S. Vet. License No. 303; Novartis Animal Health US, Inc., Larchwood, IA 51241 USA; ©2010 Novartis; Registered trademark of Novartis AG
NAC No.: 1114028.7
Farm Animal Business
1447 140TH ST., LARCHWOOD, IA, 51241
|Every effort has been made to ensure the accuracy of the Parvo Shield L5E information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the US product label or package insert.|
Copyright © 2016 North American Compendiums. Updated: 2016-04-29